section name header
Index
20 Mcg Versus over 20 Mcg Estrogen Combined Oral Contraceptives for Contraception
Administration
Behavioral Interventions for Improving Condom Use for Dual Protection
Biphasic Versus Monophasic Oral Contraceptives
Biphasic Versus Triphasic Oral Contraceptives for Contraception
Breast Cancer and Hormonal Contraceptives
Cardiology
Cochrane review
Combination Contraceptives: Effects on Weight
Combination Injectable Contraceptives for Contraception
Combined Contraceptives in Women Without Diabetes Mellitus
Combined Hormonal Versus Non-Hormonal Versus Progestin-Only Contraception in Lactation
Combined Oral Contraceptive Pill for Primary Dysmenorrhoea
Combined Oral Contraceptive Pills (Cocs) for Treatment of Acne
Combined Oral Contraceptives and Bone Mineral Density
Combined Oral Contraceptives and Bone Mineral Density
Combined Oral Contraceptives for Heavy Menstrual Bleeding
Combined Oral Contraceptives for Premenstrual Syndrome
Continuous or Extended Cycle Use of Combined Oral Contraceptives
Cyproterone Acetate for Hirsutism
Effect of Combined Oral Contraceptives on Libido
Endocrinology
Evidence summary
Female
Gynaecology
Hormonal Contraception in Overweight or Obese Women
Hormonal Contraception - Related Resources
Hormonal Versus Non-Hormonal Contraceptives in Women with Diabetes Mellitus Type 1 and 2
Hormone Replacement Therapy and Risk of Venous Thromboembolism
Immediate Start of Hormonal Contraceptives for Contraception
Internal medicine
Interventions for Emergency Contraception
Interventions for Preventing Unintended Pregnancies Among Adolescents
Interventions to Improve Contraception Use
Ischaemic Stroke and Myocardial Infarction Risk with Combined Oral Contraceptives
Levonorgestrel Intrauterine System Vs. other Forms of Reversible Contraceptives
Levonorgestrel-Releasing Intrauterine Device (LNG-IUD) for Symptomatic Endometriosis Following Surgery
Long Acting Progestin Contraceptives and Bone Mineral Density
Medical Therapy for Endometriosis Surgery
Metformin for Hirsutism
Metformin Vs. Combined Oral Contraceptive Pills for Symptoms and Risks Associated with Polycystic Ovary Syndrome
Neoplastic diseases
Neurology
Obstetrics
Oncology
Oral Contraceptives and the Risk of Endometrial Cancer
Oral Contraceptives and the Risk of Ovarian Cancer
Oral Contraceptives Containing Drospirenone for Premenstrual Syndrome
Oral Contraceptives for Functional Ovarian Cysts
Oral Contraceptives in Patients Who have Experienced One Venous Thrombosis
Oral Contraceptives in the Treatment of Endometriosis
Oral Contraceptives in Women with Systemic Lupus Erythematosus
Ovarian Cancer and Hormone Replacement Therapy
Premenstrual Syndrome (Pms) - Related Resources
Progestin-Only Contraceptives: Effects on Weight
Progestin-Only Pills for Contraception
Progestogen-Releasing Intrauterine System for Uterine Fibroids
Progestogens in Combined Oral Contraceptives
Repeated Use of Pre- and Postcoital Hormonal Contraception for Prevention of Pregnancy
Rheumatology
Risk of Ischaemic Stroke in People with Migraine
Risk of Myocardial Infarction in Users of Third Generation Oral Contraceptives
Risk of Venous Thromboembolism in Users of Combined Oral Contraceptives
Risk of Venous Thromboembolism with the Use of Oral Contraceptives
Risk of Venous Thrombosis in Users of 3rd Vs. 2nd Generation Combined Oral Contraceptives
Skin Patch and Vaginal Ring Versus Combined Oral Contraceptives for Contraception
Subdermal Implantable Contraceptives for Preventing Pregnancy
Surgery
Systematic review
Systemic Lupus Erythematosus (Sle) - Related Resources
Third Generation Oral Contraceptives and Risk of Venous Thromboembolism
Treatment of Deep Venous Thrombosis
Treatment of Vaginal Bleeding Irregularities Induced by Progestin Only Contraceptives
Triphasic Versus Monophasic Oral Contraceptives for Contraception